Mineralys Therapeutics Inc (MLYS)
29.23
-2.44%
Mineralys Therapeutics Inc (MLYS) is currently trading at $29.23. This represents a loss of 2.44% from the previous session. With a market capitalization of $2.31B, MLYS is a key component of the Health Care sector. Investors looking to trade MLYS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade MLYS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Mineralys Therapeutics Inc (MLYS) shows a bearish trend. Analysts are watching the 29.97 level closely.
Fundamentals
Mkt Cap2.31B
P/E Ratio0.0000
Volume820,279
60-Day Technical Chart
Advanced Charting
Need more indicators for MLYS? Use the world's #1 platform.
Open MLYS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $29
| Metric |
MLYS -2.44% |
T -1.69% |
PFE -0.18% |
CMCSA -2.59% |
|---|---|---|---|---|
| Price | $29.23 | $27.87 | $27.09 | $30.79 |
| Mkt Cap | $2.31B | $195.11B | $154.03B | $110.78B |
| - | View → | View → | View → |
Latest Headlines
Mineralys Therapeutics (MLYS) Files Lorundrostat NDA Following Positive Clinical Milestones
Yahoo Finance • Jan 29, 2026
Rodman sells Mineralys Therapeutics (MLYS) stock for $11,505
Investing.com • Feb 17, 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Feb 11, 2026
$MLYS stock is up 87% today. Here's what we see in our data.
Quiver Quantitative • Sep 2, 2025
$175 Million Stock Offering: Mineralys Therapeutics Seeks Funding for Hypertension Drug Development
Stock Titan • Sep 2, 2025
● Gemini Agentic AI Analyst Insight for MLYS
Market Education
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
- Tax Loss Selling: A Strategic Way to Offset Gains Dec 10, 2024
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
External Research